Back to today’s briefing

Story perspectives

FDA Stands Firm on Mifepristone Amid Conservative Backlash

4/26/2025

42 6

Summary

Story summary

FDA Commissioner Marty Makary reassured the public that there are no immediate plans to limit access to mifepristone, the abortion pill, unless safety issues emerge. His remarks sparked backlash from conservatives, notably Senator Josh Hawley, who voiced his discontent with the FDA's stance at the Semafor World Economy Summit, highlighting the ongoing tension surrounding reproductive health policies.

1 of 1

Story summary

FDA Commissioner Marty Makary reassured the public that there are no immediate plans to limit access to mifepristone, the abortion pill, unless safety issues emerge. His remarks sparked backlash from conservatives, notably Senator Josh Hawley, who voiced his discontent with the FDA's stance at the Semafor World Economy Summit, highlighting the ongoing tension surrounding reproductive health policies.